Shyam Srinivasan
Stock Analyst at Goldman Sachs
(0.28)
# 4,228
Out of 4,455 analysts
83
Total ratings
46.2%
Success rate
-11.5%
Average return
Main Sectors:
Stocks Rated by Shyam Srinivasan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NSE: DIVISLAB Divi's Laboratories Limited | Upgraded: Buy | ₹6,375 → ₹8,035 | $6,700.00 | +19.93% | 6 | May 29, 2026 | |
| NSE: DRREDDY Dr. Reddy's Laboratories Limited | Downgraded: Sell | ₹1,200 → ₹1,075 | $1,349.50 | -20.34% | 6 | Apr 23, 2026 | |
| NSE: APOLLOHOSP Apollo Hospitals Enterprise Limited | Maintained: Buy | ₹7,850 → ₹8,550 | $8,585.00 | -0.41% | 2 | Dec 7, 2025 | |
| NSE: FORTIS Fortis Healthcare Limited | Downgraded: Hold | ₹700.00 → ₹965.00 | $953.50 | +1.21% | 2 | Dec 7, 2025 | |
| NSE: KIMS Krishna Institute of Medical Sciences Limited | Initiated Coverage: Buy | ₹900.00 | $794.00 | +13.35% | 1 | Dec 7, 2025 | |
| NSE: MAXHEALTH Max Healthcare Institute Limited | Initiated Coverage: Buy | ₹1,325 | $1,122.90 | +18.00% | 1 | Dec 7, 2025 | |
| NSE: ICICIPRULI ICICI Prudential Life Insurance Company Limited | Maintained: Hold | ₹625.00 → ₹650.00 | $491.10 | +32.36% | 3 | Oct 15, 2025 | |
| NSE: LAURUSLABS Laurus Labs Limited | Maintained: Sell | ₹675.00 → ₹750.00 | $1,453.10 | -48.39% | 8 | Oct 14, 2025 | |
| NSE: NEULANDLAB Neuland Laboratories Limited | Maintained: Buy | ₹15,750 → ₹17,225 | $17,968.00 | -4.14% | 5 | Oct 14, 2025 | |
| NSE: BIOCON Biocon Limited | Maintained: Hold | ₹345.00 → ₹335.00 | $416.00 | -19.47% | 6 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹800.00 → ₹775.00 | $437.40 | +77.18% | 5 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹1,300 → ₹1,250 | $1,554.60 | -19.59% | 3 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | ₹1,375 → ₹1,350 | $1,439.20 | -6.20% | 5 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | ₹1,435 → ₹1,525 | $2,313.00 | -34.07% | 5 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹1,975 | $2,348.50 | -15.90% | 4 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹265.00 → ₹250.00 | $167.45 | +49.30% | 3 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹830.00 → ₹890.00 | $584.80 | +52.19% | 2 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹465.00 | $423.25 | +9.86% | 1 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹1,860 → ₹2,015 | $1,742.00 | +15.67% | 3 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | ₹1,650 → ₹1,680 | $1,766.90 | n/a | 2 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | ₹1,325 | $1,691.00 | n/a | 1 | Apr 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | ₹1,475 → ₹1,500 | $1,861.50 | n/a | 4 | Apr 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | ₹1,350 | $456.60 | n/a | 1 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | ₹1,675 | $544.95 | n/a | 1 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹1,975 | $1,819.90 | n/a | 1 | Jan 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $0.92 | n/a | 1 | Jul 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $15.38 | n/a | 1 | May 2, 2016 |
Divi's Laboratories Limited
May 29, 2026
Upgraded: Buy
Price Target: ₹6,375 → ₹8,035
Current: $6,700.00
Upside: +19.93%
Dr. Reddy's Laboratories Limited
Apr 23, 2026
Downgraded: Sell
Price Target: ₹1,200 → ₹1,075
Current: $1,349.50
Upside: -20.34%
Apollo Hospitals Enterprise Limited
Dec 7, 2025
Maintained: Buy
Price Target: ₹7,850 → ₹8,550
Current: $8,585.00
Upside: -0.41%
Fortis Healthcare Limited
Dec 7, 2025
Downgraded: Hold
Price Target: ₹700.00 → ₹965.00
Current: $953.50
Upside: +1.21%
Krishna Institute of Medical Sciences Limited
Dec 7, 2025
Initiated Coverage: Buy
Price Target: ₹900.00
Current: $794.00
Upside: +13.35%
Max Healthcare Institute Limited
Dec 7, 2025
Initiated Coverage: Buy
Price Target: ₹1,325
Current: $1,122.90
Upside: +18.00%
ICICI Prudential Life Insurance Company Limited
Oct 15, 2025
Maintained: Hold
Price Target: ₹625.00 → ₹650.00
Current: $491.10
Upside: +32.36%
Laurus Labs Limited
Oct 14, 2025
Maintained: Sell
Price Target: ₹675.00 → ₹750.00
Current: $1,453.10
Upside: -48.39%
Neuland Laboratories Limited
Oct 14, 2025
Maintained: Buy
Price Target: ₹15,750 → ₹17,225
Current: $17,968.00
Upside: -4.14%
Biocon Limited
Aug 8, 2025
Maintained: Hold
Price Target: ₹345.00 → ₹335.00
Current: $416.00
Upside: -19.47%
Jul 24, 2025
Maintained: Buy
Price Target: ₹800.00 → ₹775.00
Current: $437.40
Upside: +77.18%
Jul 15, 2025
Maintained: Buy
Price Target: ₹1,300 → ₹1,250
Current: $1,554.60
Upside: -19.59%
Jul 15, 2025
Maintained: Sell
Price Target: ₹1,375 → ₹1,350
Current: $1,439.20
Upside: -6.20%
Jul 15, 2025
Maintained: Sell
Price Target: ₹1,435 → ₹1,525
Current: $2,313.00
Upside: -34.07%
Jul 15, 2025
Maintained: Hold
Price Target: ₹1,975
Current: $2,348.50
Upside: -15.90%
Jul 15, 2025
Maintained: Buy
Price Target: ₹265.00 → ₹250.00
Current: $167.45
Upside: +49.30%
Jul 8, 2025
Maintained: Buy
Price Target: ₹830.00 → ₹890.00
Current: $584.80
Upside: +52.19%
Jul 8, 2025
Maintained: Hold
Price Target: ₹465.00
Current: $423.25
Upside: +9.86%
Jul 8, 2025
Maintained: Buy
Price Target: ₹1,860 → ₹2,015
Current: $1,742.00
Upside: +15.67%
May 2, 2025
Maintained: Sell
Price Target: ₹1,650 → ₹1,680
Current: $1,766.90
Upside: n/a
Apr 26, 2025
Maintained: Sell
Price Target: ₹1,325
Current: $1,691.00
Upside: n/a
Apr 18, 2025
Maintained: Sell
Price Target: ₹1,475 → ₹1,500
Current: $1,861.50
Upside: n/a
Apr 8, 2025
Initiated Coverage: Buy
Price Target: ₹1,350
Current: $456.60
Upside: n/a
Feb 6, 2025
Maintained: Sell
Price Target: ₹1,675
Current: $544.95
Upside: n/a
Jan 19, 2025
Maintained: Hold
Price Target: ₹1,975
Current: $1,819.90
Upside: n/a
Jul 26, 2021
Maintained: Hold
Price Target: n/a
Current: $0.92
Upside: n/a
May 2, 2016
Initiated Coverage: Hold
Price Target: n/a
Current: $15.38
Upside: n/a